Skip to main content
Edwards Lifesciences Logo

Comunicados de prensa

newsroom banner image
October 01, 2026
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
September 10, 2026
Edwards Lifesciences Comments on TAVR National Coverage Decision
September 02, 2026
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
July 23, 2026
Edwards Lifesciences Reports Second Quarter Results
July 16, 2026
Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026

Contactos

Investors

Mark Wilterding
(SVP, Investor Relations)